NO20003159L - Dobbelkapsel til administrering av aktive prinsipp ved multippel terapier - Google Patents

Dobbelkapsel til administrering av aktive prinsipp ved multippel terapier

Info

Publication number
NO20003159L
NO20003159L NO20003159A NO20003159A NO20003159L NO 20003159 L NO20003159 L NO 20003159L NO 20003159 A NO20003159 A NO 20003159A NO 20003159 A NO20003159 A NO 20003159A NO 20003159 L NO20003159 L NO 20003159L
Authority
NO
Norway
Prior art keywords
administration
active principles
multiple therapies
double capsule
capsule
Prior art date
Application number
NO20003159A
Other languages
English (en)
Other versions
NO20003159D0 (no
NO329126B1 (no
Inventor
Giovanni Sanso
Original Assignee
Axcan Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11378381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003159(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Axcan Pharma Inc filed Critical Axcan Pharma Inc
Publication of NO20003159D0 publication Critical patent/NO20003159D0/no
Publication of NO20003159L publication Critical patent/NO20003159L/no
Publication of NO329126B1 publication Critical patent/NO329126B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20003159A 1997-12-17 2000-06-16 Anvendelse av et loselig salt av vismut, et forste antibiotikum og et andre antibiotikum, eventuelt ogsa og en K+ /Na+ ATPase-inhibitor eller anti-H2 , for fremstilling av en farmasoytisk doseringsform for en multiterapi mot mikroorganismene Helicobacter pylori, og farmasoytiske doseringsformer inneholdende det samme i en dobbeltkapsel. NO329126B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002788A IT1296980B1 (it) 1997-12-17 1997-12-17 Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
PCT/EP1998/008167 WO1999030693A2 (en) 1997-12-17 1998-12-14 A double capsule for the administration of active principles in multiple therapies

Publications (3)

Publication Number Publication Date
NO20003159D0 NO20003159D0 (no) 2000-06-16
NO20003159L true NO20003159L (no) 2000-08-16
NO329126B1 NO329126B1 (no) 2010-08-30

Family

ID=11378381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003159A NO329126B1 (no) 1997-12-17 2000-06-16 Anvendelse av et loselig salt av vismut, et forste antibiotikum og et andre antibiotikum, eventuelt ogsa og en K+ /Na+ ATPase-inhibitor eller anti-H2 , for fremstilling av en farmasoytisk doseringsform for en multiterapi mot mikroorganismene Helicobacter pylori, og farmasoytiske doseringsformer inneholdende det samme i en dobbeltkapsel.

Country Status (26)

Country Link
US (1) US6350468B1 (no)
EP (1) EP1037614B1 (no)
JP (1) JP4615713B2 (no)
KR (1) KR100509351B1 (no)
CN (1) CN1147292C (no)
AR (1) AR014126A1 (no)
AT (1) ATE254910T1 (no)
AU (1) AU743090B2 (no)
BR (1) BR9812803A (no)
CA (1) CA2315408C (no)
CZ (1) CZ299181B6 (no)
DE (1) DE69820108T2 (no)
DK (1) DK1037614T3 (no)
ES (1) ES2212391T3 (no)
HK (1) HK1034897A1 (no)
HU (1) HU225690B1 (no)
ID (1) ID26340A (no)
IT (1) IT1296980B1 (no)
MY (1) MY121713A (no)
NO (1) NO329126B1 (no)
NZ (1) NZ505655A (no)
PE (1) PE20000512A1 (no)
PL (1) PL192541B1 (no)
PT (1) PT1037614E (no)
TR (1) TR200001761T2 (no)
WO (1) WO1999030693A2 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
GB0017673D0 (en) * 2000-07-20 2000-09-06 Mw Encap Limited Delivery device
AU2001272645A1 (en) * 2000-07-20 2002-02-05 Mw Encap Limited Delivery device
US20040105883A1 (en) * 2001-04-17 2004-06-03 Ping Gao Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
US20040105885A1 (en) * 2001-04-17 2004-06-03 Ping Gao Gelatin capsule exhibiting reduced cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US6726809B2 (en) * 2001-09-26 2004-04-27 Albany International Corp. Industrial process fabric
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
WO2004060379A2 (en) * 2003-01-03 2004-07-22 Milankovits Marton Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
WO2005039474A1 (en) * 2003-10-21 2005-05-06 Ambo Innovation Llc Digestible and volume adjustable multi medication delivery device
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CN100350900C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方降香双相胶囊及其制备方法
CN100350898C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方三七双相胶囊及其制备方法
CN100350899C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 冠心丹参双相胶囊及其制备方法
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
WO2007047371A2 (en) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Pharmaceutical packaging of an oral dosage combination
CN100393359C (zh) * 2005-12-13 2008-06-11 济南百诺医药科技开发有限公司 根除幽门螺旋杆菌的多单元组合物
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
AU2007278986B2 (en) * 2006-07-25 2010-09-16 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN101513395B (zh) * 2008-02-20 2011-01-12 单宝华 紫杉醇类双层软胶囊口服制剂药物
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
TWI463998B (zh) 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
CN102349887A (zh) * 2011-08-02 2012-02-15 天津市嵩锐医药科技有限公司 双氯芬酸钠对乙酰氨基酚胃肠型胶囊药物组合物
ITMI20120350A1 (it) * 2012-03-06 2013-09-07 Ultimate Italia S A S Di Levantino Enrico E C Forma di dosaggio per somministrazione orale di principi attivi
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
US9700514B1 (en) * 2014-08-20 2017-07-11 Darren Rubin Single solid oral dosage forms for treating Helicobacter pylori infection and duodenal ulcer disease
CN105106162A (zh) * 2015-08-21 2015-12-02 四川百利药业有限责任公司 一种治疗幽门螺杆菌所引起溃疡的复方片剂及其制备方法
WO2017223043A1 (en) * 2016-06-22 2017-12-28 University Of Florida Research Foundation, Inc. Pharmaceutical capsules for medication adherence monitoring and methods of forming the same
CN108186968B (zh) * 2018-01-08 2021-07-20 江苏聚荣制药集团有限公司 温胃舒胶囊

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072528A (en) 1957-07-13 1963-01-08 Med Fabrik Chemisch Pharmazeut Ingestible dry microorganism preparations
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
DE2729068A1 (de) 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CA1143287A (en) * 1981-08-11 1983-03-22 William C. Stewart Waterproof edible encapsulation for prophylactic drugs
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4642233A (en) 1982-03-22 1987-02-10 Alza Corporation Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills
FR2524311A1 (fr) * 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
JPS59131355A (ja) 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
JPS60193917A (ja) * 1984-03-14 1985-10-02 R P Shiila- Kk 多重構造軟カプセル剤
US4627808A (en) 1985-05-31 1986-12-09 Hughes Raymond J Apparatus for making capsule having plural chambers
US5256684A (en) 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4936461A (en) 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4822619A (en) 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5394980A (en) 1987-06-30 1995-03-07 Tsai; Min H. Multicompartment mixing capsule
DE3887353T2 (de) 1987-10-12 1994-05-05 Exomed Australia Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
US5192752A (en) 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5472695A (en) 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
US5501857A (en) 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5310555A (en) 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
EP0804174A4 (en) 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
US5560912A (en) 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit

Also Published As

Publication number Publication date
PE20000512A1 (es) 2000-06-13
CZ299181B6 (cs) 2008-05-14
JP4615713B2 (ja) 2011-01-19
AR014126A1 (es) 2001-02-07
HUP0100095A3 (en) 2001-12-28
NO20003159D0 (no) 2000-06-16
KR100509351B1 (ko) 2005-08-22
HK1034897A1 (en) 2001-11-09
CZ20002231A3 (cs) 2000-11-15
JP2002508312A (ja) 2002-03-19
CA2315408A1 (en) 1999-06-24
AU743090B2 (en) 2002-01-17
ATE254910T1 (de) 2003-12-15
AU2413599A (en) 1999-07-05
DE69820108T2 (de) 2004-09-09
CN1285741A (zh) 2001-02-28
EP1037614A2 (en) 2000-09-27
MY121713A (en) 2006-02-28
CN1147292C (zh) 2004-04-28
ID26340A (id) 2000-12-14
NO329126B1 (no) 2010-08-30
EP1037614B1 (en) 2003-11-26
ITMI972788A1 (it) 1999-06-17
PT1037614E (pt) 2004-04-30
TR200001761T2 (tr) 2000-10-23
HU225690B1 (en) 2007-06-28
HUP0100095A2 (hu) 2001-06-28
DK1037614T3 (da) 2004-04-05
IT1296980B1 (it) 1999-08-03
ES2212391T3 (es) 2004-07-16
CA2315408C (en) 2005-05-24
WO1999030693A2 (en) 1999-06-24
WO1999030693A3 (en) 1999-09-02
NZ505655A (en) 2003-09-26
PL192541B1 (pl) 2006-11-30
BR9812803A (pt) 2000-10-03
US6350468B1 (en) 2002-02-26
PL341737A1 (en) 2001-05-07
KR20010033244A (ko) 2001-04-25
DE69820108D1 (de) 2004-01-08

Similar Documents

Publication Publication Date Title
NO20003159L (no) Dobbelkapsel til administrering av aktive prinsipp ved multippel terapier
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
ATE238812T1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE122005000024I1 (de) Darifenacin enthaltende Pharmazeutische Zubereitungen.
FI972292A0 (fi) Administrering av diabetes
NO20002129D0 (no) Indazol-bioisoster erstatning av catechol i terapeutiske aktive forbindelser
AU5609998A (en) Tablet for the controlled release of active agents
AU7277498A (en) Cyber medicine disease management
DE69813602T2 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
NO308527B1 (no) Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
DZ2560A1 (fr) Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
DE69713505T2 (de) Arzneimittel enthaltend mizolastin mit verzögerter wirkstoffabgabe
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
AU9462498A (en) Hysteromyoma remedy containing dienogest as the active ingredient
IT1289953B1 (it) Dispositivo di riscaldamento di tavolette per la vaporizzazione di sostanze attive
NO308737B1 (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres anvendelse ved fremstilling av et legemiddel, og farmasøytiske preparater inneholdende disse

Legal Events

Date Code Title Description
MK1K Patent expired